Lipopolysaccharide adsorber in abdominal septic shock

doi:10.1186/cc7444

Top
Introduction
Methods
Results
Conclusion
References

Critical Care
Volume 13
Suppl 1

Viewing options:

Full text
PDF (7.4MB)

Related literature:

Articles citing this article
on Google Scholar
Other articles by authors
on Google Scholar

Ala-Kokko T
Koskenkari J
Laurila J

on PubMed

Ala-Kokko T
Koskenkari J
Laurila J
Related articles/pages
on Google

on Google Scholar

Tools:

Nominate for award

Post to:

This article is part of the supplement: 29th International Symposium on Intensive Care and Emergency Medicine .

Poster presentation

Lipopolysaccharide adsorber in abdominal septic shock

T Ala-Kokko, J Koskenkari and J Laurila

Oulu University Hospital, Oulu, Finland

from 29th International Symposium on Intensive Care and Emergency Medicine
Brussels, Belgium. 24–27 March 2009

Critical Care 2009, 13(Suppl 1):P280doi:10.1186/cc7444

The electronic version of this abstract is the complete one and can be found online at: http://ccforum.com/content/13/S1/P280

Published:

13 March 2009

Introduction

Polymyxin-B hemoperfusion has been shown to lower mortality in sepsis [1]. The effects of a new endotoxin adsorber (Alteco LPS Adsorber; Alteco Medical AB, Lund, Sweden) on the length of noradrenaline (NA) treatment and lipopolysaccharide blood levels in abdominal septic shock were evaluated.

Methods

Following consent a 2-hour hemoperfusion with LPS adsorber was began in five patients [2]. Sepsis guidelines were followed [3]. Two historical controls per case were selected.

Results

The mean total duration of NA infusion was 46 hours shorter in the adsorber group compared with the control group (95% CI = -104 hours to 12 hours, P = 0.165) (Table 1). The average length of NA infusion was 17.4 ± 6.8 hours (5.8 to 23.8 hours) following the start of adsorption treatment. The level of LPS decreased in all but one study patient and all were without NA at 24 hours. The mean Sequential Organ Failure Assessment decrease was 3.4 ± 1.7 from baseline to 24 hours post treatment The average length of hospital stay was 3.4 days shorter in the adsorber group (95% CI of the difference, -21.7 to 14.8 days, P = 0.881). All study patients were alive on day 28 and one control died in the hospital.

Table 1. Clinical characteristics of the study patients and the controls

Conclusion

Single 2-hour LPS hemoperfusion was associated with a rapid decrease in NA dose, reversal of septic shock, and decrease in organ dysfunctions and LPS concentrations. The total duration of NA infusion and hospital stay were shorter compared with historical controls, but the difference was not statistically significant in this small study.

References

Cruz D, et al.: Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review.
Crit Care 2007, 11:R47. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text
Levy MM, et al.: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.
Crit Care Med 2001, 31:1250-1256. Publisher Full Text
Dellinger RP, et al.: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.
Crit Care Med 2008, 36:296-327. PubMed Abstract | Publisher Full Text

This article is part of the supplement: 29th International Symposium on Intensive Care and Emergency Medicine .

Lipopolysaccharide adsorber in abdominal septic shock

Introduction

Methods

Results

Conclusion

References

Have something to say? Post a comment on this article!